Try our Advanced Search for more refined results

In Re: Nuvaring Products Liability Litigation

Track this case

Case Number:

4:08-md-01964

Court:

Missouri Eastern

Nature of Suit:

Personal Inj. Prod. Liability

Multi Party Litigation:

Multi-district Litigation

Judge:

Rodney W. Sippel

Firms

Companies

Sectors & Industries:

March 22, 2013
Doc Testimony Over Discontinuing NuvaRing Axed From MDL

A Missouri judge on Friday rejected a doctor's testimony arguing the contraceptive NuvaRing should be pulled from the market, but refused to exclude future testimony to that effect in the sprawling product liability multidistrict litigation against a Merck & Co. Inc. subsidiary.
October 26, 2012
Merck Can't Shield Testimony Docs In NuvaRing MDL

A Missouri federal judge overseeing product liability multidistrict litigation against a Merck & Co. Inc. subsidiary over the contraceptive NuvaRing on Thursday rejected a bid by the company to seal a set of documents it argued could be damaging to its reputation.
February 13, 2012
Judge OKs 3 New Bellwethers In NuvaRing MDL

A Missouri federal judge named three new cases as bellwethers Monday in the multidistrict litigation accusing Merck & Co. Inc. of downplaying the health risks of contraceptive NuvaRing.
April 12, 2011
Parties Offer Bellwether Plan In NuvaRing MDL

Attorneys for Organon International Inc. and plaintiffs accusing the company in a multidistrict litigation in Missouri of downplaying the health risks of contraceptive NuvaRing on Monday jointly offered a pathway for selecting bellwether cases for trial.
August 12, 2009
NuvaRing Maker Ordered To Pay E-Discovery Costs

The federal judge overseeing the multidistrict litigation over Schering-Plough Corp. unit Organon International Inc.'s NuvaRing contraceptive has denied the company's request that the plaintiffs in the case share the cost of e-discovery, which has reached almost $2 million to date.
August 06, 2009
Organon Loses Bid To Nix NuvaRing Complaint

The federal judge overseeing the multidistrict litigation regarding Schering-Plough Corp. unit Organon International Inc.'s NuvaRing contraceptive has rejected the company's request to have the master consolidated complaint in the case tossed.
March 23, 2009
Organon Denied Ex Parte Contact In NuvaRing MDL

Organon International Inc. is not allowed to have ex parte communications with plaintiffs' health care providers in the multidistrict litigation over the drug company's NuvaRing contraceptive, a federal judge has ruled.
March 09, 2009
Preemption Motion Withdrawn In NuvaRing MDL

Days after the U.S. Supreme Court's decision in Wyeth v. Levine, attorneys for Organon International Inc. in the multidistrict litigation over its NuvaRing contraceptive have withdrawn a motion that sought summary judgment on preemption grounds.